Vascular aspects of oestrogen

Maturitas

Volumn 23, Issue 2, 1996, Pages 217-226

  Collins, P ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; NITRIC OXIDE;

ADULT; BLOOD FLOW; BRAIN CIRCULATION; CALCIUM ANTAGONISM; CONFERENCE PAPER; DRUG EFFECT; ENDOTHELIUM; ESTROGEN DEFICIENCY; FEMALE; HEMODYNAMICS; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE;

EID: 0029952503     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5122(95)00997-3     Document Type: Conference Paper

References (97)

1. Godsland IF, Wynn V, Crook D, Miller NE. Sex, plasma lipoproteins, and atherosclerosis: prevailing assumptions and outstanding questions. Am Heart J 1987; 114: 1467-1503.
2. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med 1991; 20: 47-63.
3. Sarrel PM. Ovarian hormones and the circulation. Maturitas 1990; 12: 287-298.
4. Gruchow HW, Anderson AJ, Barboriak JJ, Sobocinski KA. Postmenopausal use of estrogen and occlusion of coronary arteries. Am Heart J 1988; 115: 954-963.
5. Sullivan JM, Vander Zwaag R, Lemp GF et al. Postmenopausal estrogen use and coronary atherosclerosis. Ann Intern Med 1988; 108: 358-363.
6. Adams MR, Clarkson TB, Kaplan JR, Koritnik DR: Ovarian secretions and atherosclerosis. In: Naftolin F, Gutmann JN, DeCherney AH, Sarrel PM, eds. Ovarian secretions and cardiovascular and neurological function. New York: Raven Press, 1990, pp. 151-159.
7. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. J Am Med Assoc 1991; 265: 1861-1867.
8. Davis LE, Magness RR, Rosenfeld CR. Role of angiotensin II and α-adrenergic receptors during estrogen-induced vasodilation in ewes. Am J Physiol 1992; 263: E837-E843.
9. Killam AP, Rosenfeld CR, Battaglia FC, Makowski EL, Meschia G. Effect of estrogens on the uterine blood flow of oophorectomized ewes. Am J Obstet Gynecol 1973; 115: 1045-1052.
10. Greiss FC Jr, Anderson SG. Effect of ovarian hormones on the uterine vascular bed. Am J Obstet Gynecol 1970; 107: 829-836.
11. Markee JE. Rhythmic vascular uterine changes. Am J Physiol 1932; 100: 32-39.
12. Rosenfeld CR. Responses of reproductive and nonreproductive tissues to 17β-estradiol during ovine puerperium. Am J Physiol 1980; 239: E333-E339.
13. Rosenfeld CR, Killam AP, Battaglia FC, Makowski EL, Meschia G. Effect of estradiol-17, on the magnitude and distribution of uterine blood flow in nonpregnant, oophorectomized ewes. Pediatr Res 1973; 7: 139-148.
14. Rosenfeld CR, Morriss FH Jr, Battaglia FC, Makowski EL, Meschia G. Effect of estradiol-17β on blood flow to reproductive and nonproductive tissues in pregnant ewes. Am J Obstet Gynecol 1976; 124: 618-629.
15. Magness RR, Rosenfeld CR. Local and systemic estradiol-17β: effects on uterine and systemic vasodilation. Am J Physiol 1989; 256: E536-E542.
16. Rosenfeld CR, Jackson GM. Estrogen-induced refractoriness to the pressor effects of infused angiotensin II. Am J Obstet Gynecol 1984; 148: 429-435.
17. Slater AJ, Gude N, Clarke IJ, Walters WA. Haemodynamic changes and left ventricular performance during high-dose oestrogen administration to male transsexuals. Br J Obstet Gynaecol 1986; 93: 532-538.
18. Walters WA, Lim YL. Haemodynamic changes in women taking oral contraceptives. J Obstet Gynaecol Br Comm 1970; 77: 1007-1012.
19. Naden RP, Rosenfeld CR. Role of α-receptors in estrogen-induced vasodilation in nonpregnant sheep. Am J Physiol 1985; 248: H339-H344.
20. Ford SP, Christenson RK. Blood flow to uteri of sows during the estrous cycle and early pregnancy: local effect of the conceptus on the uterine blood supply. Biol Reprod 1979; 21: 617-624.
21. Prill HJ, Götz F. Blood flow in the myometrium and endometrium of the uterus. Am J Obstet Gynecol 1961; 82: 102-108.
22. Greiss FCJr, Rose JC, Kute TE, Kelly RT, Winkler LS. Temporal and receptor correlates of the estrogen response in sheep. Am J Obstet Gynecol 1986; 154: 831-838.
23. Van Buren G, Yang D, Clark KE. Estrogen-induced uterine vasodilatation is antagonized by L-nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 1992; 16: 828-833.
24. Paganini-Hill A, Ross RK, Henderson BE. Postmenopausal oestrogen treatment and stroke: a prospective study. Br Med J 1988; 297: 519-522.
25. Falkeborn M, Persson I, Terent A, Adami HO, Lithell H, Bergstrom R. Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden. Arch Intern Med 1993; 153: 1201-1209.
26. Finucane FF, Madans JH, Bush TL, Wolf PH, Kleinman JC. Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort. Arch Intern Med 1993; 153: 73-79.
27. Shaw TG, Mortel KF, Meyer JS, Rogers RL, Hardenberg J, Cutaia MM. Cerebral blood flow changes in benign aging and cerebrovascular disease. Neurology 1984; 34: 855-862.
28. Rodriguez G, Warkentin S, Risberg J, Rosadini G. Sex differences in regional cerebral blood flow. J Cereb Blood Flow Metab 1988; 8: 783-789.
29. Ganger KF, Vyas S, Whitehead M, Crook D, Meire H, Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991; 338: 839-842.
30. Penotti M, Nencioni T, Gabrielli L, Farina M, Castiglioni E, Polvani F. Blood flow variations in internal carotid and middle cerebral arteries induced by postmenopausal hormone replacement therapy. Am J Obstet Gynecol 1993; 169: 1226-1232.
31. Ikeda T, Ikenoue T, Mori N et al. Effect of early pregnancy on maternal regional cerebral blood flow. Am J Obstet Gynecol 1993; 168: 1303-1308.
32. Shamma FN, Fayad P, Brass L, Sarrel P. Middle cerebral artery blood velocity during controlled ovarian hyperstimulation. Fertil Steril 1992; 57: 1022-1025.
33. Shay J, Futo J, Badrov N, Moss J. Estrogen withdrawal selectively increases serotonin reactivity in rabbit basilar artery. Life Sci 1994; 55: 1071-1081.
34. Hall ED, Pazara KE, Linseman KL. Sex differences in postischemic neuronal necrosis in gerbils. J Cereb Blood Flow Metab 1991; 11: 292-298.
35. Hurn PD, Littleton-Kearney MT, Kirsch JR, Dharmarajan AM, Traystman RJ. Postischemic cerebral blood flow recovery in the female: effect of 17β-estradiol. J Cereb Blood Flow Metab 1995; 15: 666-672.
36. Belfort MA, Saade GR, Snabes M et al. Hormonal status affects the reactivity of the cerebral vasculature. Am J Obstet Gynecol 1995; 172: 1273-1278.
37. Raddino R, Manca C, Poli E, Bolognesi R, Visioli O. Effects of 17β-estradiol on the isolated rabbit heart. Arch Int Pharmacodyn Ther 1986; 281: 57-65.
38. Gorodeski GI, Utian WH, Levy MN. Estrogen increases coronary flow by a nitric oxide related mechanism. 5th Annual Meeting of the North American Menopause Society, Washington DC 1994: (Abstr.).
39. Volterrani M, Rosano GMC, Coats A, Beale C, Collins P. Estrogen acutely increases peripheral blood flow in postmenopausal women. Am J Med 1995; 99: 119-122.
40. Pfeffer RI, van den Noort S. Estrogen use and stroke risk in postmenopausal women. Am J Epidemiol 1976; 103: 445-456.
41. Pfeffer RI, Kurosaki TT, Charlton SK. Estrogen use and blood pressure in later life. Am J Epidemiol 1979; 110: 469-478.
42. Hammond CB, Jelovsek FR, Lee KL, Creasman WT, Parker RT. Effects of long-term estrogen replacement therapy. I. Metabolic effects. Am J Obstet Gynecol 1979; 133: 525-536.
43. Lip G, Beevers M, Holmes A, Churchill D, Beevers G. Effects of hormone replacement therapy (HRT) on blood pressure in hypertensive women. J Am Coll Cardiol 1994; 348A (Abstr.).
44. Rosano GMC, Sarrel PM, Poole-Wilson PA, Collins P. Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet 1993; 342: 133-136.
45. Jilma B, Wolzt M, Wagner OF et al. In vivo study of the effect of exogenous estradiol on α-adrenoceptor responsiveness of human veins. J Cardiovasc Pharmacol 1994; 23: 859-863.
46. McGill HC Jr. Sex steroid hormone receptors in the cardiovascular system. Postgrad Med 1989; 64-68.
47. Kahn D, Zeng Q, Kajani M et al. The effect of different types of hepatic injury on the estrogen and androgen receptor activity of liver. J Invest Surg 1989; 2: 125-133.
48. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994; 89: 1501-1510.
49. Collins P, Sheppard M, Beale CM, Dowsett M. The classical estrogen receptor is not found in human coronary arteries. Circulation 1995; 92: I-37 (Abstr.).
50. Williams SP, Shackelford DP, Iams SG, Mustafa SJ. Endothelium-dependent relaxation in estrogen-treated spontaneously hypertensive rats. Eur J Pharmacol 1988; 145: 205-207.
51. Gisclard V, Miller VM, Vanhoutte PM. Effect of 17β-estradiol on endothelium-dependent responses in the rabbit. J Pharmacol Exp Ther 1988; 244: 19-22.
52. Gilligan DM, Badar DM, Panza JA, Quyyumi AA, Cannon RO III. Acute vascular effects of estrogen in postmenopausal women. Circulation 1994; 90: 786-791.
53. Weiner CP, Lizasoain I, Baylis SA, Knowles RG, Charles IG, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 1994; 91: 5212-5216.
54. Dubey RK, Overbeck HW. Culture of rat mesenteric arteriolar smooth muscle cells: effects of platelet-derived growth factor, angiotensin, and nitric oxide on growth. Cell Tissue Res 1994; 275: 133-141.
55. Sack MN, Rader DJ, Cannon RO III. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet 1994; 343: 269-270.
56. Simon BC, Cunningham LD, Cohen RA. Oxidized low density lipoproteins cause contraction and inhibit endothelium-dependent relaxation in the pig coronary artery. J Clin Invest 1990; 86: 75-79.
57. Hayashi T, Fukuto JM, Ignarro LJ, Chaudhuri G. Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis. Proc Natl Acad Sci USA 1992; 89: 11259-11263.
58. Collins P, Shay J, Jiang C, Moss J. Nitric oxide accounts for dose-dependent estrogen-mediated coronary relaxation following acute estrogen withdrawal. Circulation 1994; 90: 1964-1968.
59. Futo J, Shay J, Holt J, Moss J. Estrogen and progesterone withdrawl increases cerebral vasoreactivity to serotonin in rabbit basilar artery. Life Sci 1992; 50: 1165-1172.
60. Shay J, Badrov N, Attele A, Levinson M, Moss J. Estrogen antagonises endothelin-1 vasoconstriction in rabbit basilar artery. Anesth Analg 1993; A561.
61. Kharitonov SA, Logan-Sinclair RB, Busset CM, Shinebourne EA. Peak expiratory nitric oxide differences in men and women: relation to the menstrual cycle. Br Heart J 1994; 72: 243-245.
62. Schray-Utz B, Zeiher AM, Busse R. Expression of constitutive NO synthase in cultured endothelial cells is enhanced by 17β-estradiol. Circulation 1993; 88: 1-80 (Abstr.).
63. Sayegh HS, Ohara Y, Navas JP, Peterson TE, Dockery S, Harrison DG. Endothelial nitric oxide synthase regulation by estrogens. Circulation 1993; 88 (4): I-80 (Abstr.).
64. Caulin-Glaser TL, Sessa W, Sarrel P, Bender J. The effect of 17β-estradiol on human endothelial cell nitric oxide production. Circulation 1994; 90: I-30 (Abstr.).
65. Hishikawa K, Nakaki T, Marumo T, Suzuki H, Kato R, Saruta T. Up-regulation of nitric oxide synthase by estradiol in human aortic endothelial cells. FEBS Lett 1995; 360: 291-293.
66. Goetz RM, Morano I, Calovini T, Studer R, Holtz J. Increased expression of endothelial constitutive nitric oxide synthase in rat aorta during pregnancy. Biochem Biophys Res Commun 1994; 205: 905-910.
67. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation 1990; 81: 1680-1687.
68. Collins P, Rosano GMC, Sarrel PM et al. Estradiol-17β attenuates acetylcholine-induced coronary arterial constriction in women but not men with coronary heart disease. Circulation 1995; 92: 24-30.
69. Reis SE, Gloth ST, Blumenthal RS et al. Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women. Circulation 1994; 89: 52-60.
70. Gilligan DM, Quyyumi AA, Cannon RO III. Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women. Circulation 1994; 89: 2545-2551.
71. Miller VM, Gisclard V, Vanhoutte PM. Modulation of endothelium-dependent and vascular smooth muscle responses by estrogens. Phlebologie 1988; 224: 19-22.
72. Williams JK, Adams MR, Herrington DM, Clarkson TB. Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries. J Am Coll Cardiol 1992; 20: 452-457.
73. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-376.
74. Lieberman EH, Gerhard MD, Uehata A et al. Estrogen improves endothelium-dependent, flow-mediated vasodilation in postmenopausal women. Ann Intern Med 1994; 121: 936-941.
75. Jiang C, Sarrel PM, Lindsay DC, Poole-Wilson PA, Collins P. Endothelium-independent relaxation of rabbit coronary artery by 17β-oestradiol in vitro. Br J Pharmacol 1991; 104: 1033-1037.
76. Chester AH, Jiang C, Borland JA, Yacoub MH, Collins P. Estrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms. Cor Art Dis 1995; 6: 417-422.
77. Mügge A, Riedel M, Barton M, Kuhn M, Lichten PR. Endothelium independent relaxation of human coronary arteries by 17β-oestradiol in vitro. Cardiovasc Res 1993; 27: 1939-1942.
78. Martin W, Villani GM, Jothianandan D, Furchgott RF. Selective blockade of endothelium-dependent and glyceryl trinitrate-induced relaxation by hemoglobin and by methylene blue in the rabbit aorta. J Pharmacol Exp Ther 1985; 232: 708-716.
79. 2+ uptake of uterine arterial smooth muscle cells through potential-sensitive channels. Biol Reprod 1987; 36: 361-368.
80. 2+ channels in altering uterine blood flow during the estrous cycle and early pregnancy in gilts. Biol Reprod 1987; 36: 369-375.
81. 2+ in guinea-pig isolated cardiac myocytes. Br J Pharmacol 1992; 106: 739-745.
82. 2+ release induced by thromboxane A2 in porcine coronary artery. Circulation 1995; 91: 2619-2626.
83. 2+ currents in A7r5 vascular smooth muscle cell line. Am J Physiol 1994; 266: C975-C980.
84. Hardy SP, Valverde MA. Novel plasma membrane action of estrogen and antiestrogens revealed by their regulation of a large conductance chloride channel. FASEB J 1994; 8: 760-765.
85. Henry PD, Bentley KI. Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine. J Clin Invest 1981; 68: 1366-1369.
86. Lichtlen PR, Hugenholtz PG, Rafflenbeul W, Hecker H, Jost S, Deckers JW. Retardation of angiographic progression of coronary artery disease by nifedipine. Lancet 1990; 335: 1109-1113.
87. Waters D, Lesperance J, Francetich M, et al. A controlled clinical trial to assess the effect of a calcium channel blocker on the progression of coronary atherosclerosis. Circulation 1990; 82: 1940-1953.
88. Collins P, Rosano GMC, Jiang C, Lindsay D, Sarrel PM, Poole-Wilson PA. Hypothesis: Cardiovascular protection by oestrogen - a calcium antagonist effect? Lancet 1993; 341: 1264-1265.
89. Botting R, Vane JR: The receipt and dispatch of chemical messengers by endothelial cells. In: Schrör K, Sinzinger H, eds. Prostaglandins in clinical research: cardiovascular system. New York: Alan R. Liss, 1989, pp. 1-11.
90. Mendelsohn ME, Karas RH. Estrogen and the blood vessel wall. Curr Opin Cardiol 1994; 9: 619-626.
91. Chang WC, Nakao J, Orimo H, Murota S. Stimulation of prostacyclin biosynthetic activity by estradiol in rat aortic smooth muscle cells in culture. Biochim Biophys Acta 1980; 619: 107-118.
92. Jiang C, Sarrel PM, Poole-Wilson PA, Collins P. Acute effect of 17β-estradiol on rabbit coronary artery contractile responses to endothelin-1. Am J Physiol 1992; 263: H271-H275.
93. Lerman A, Webster MWI, Chesebro JH et al. Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs. Circulation 1993; 88: 2923-2928.
94. Cheng DY, Gruetter CA. Chronic estrogen alters contractile responsiveness to angiotensin II and norepinephrine in female rat aorta. Eur J Pharmacol 1992; 215: 171-176.
95. Magness RR, Parker CR Jr, Rosenfeld CR. Systemic and uterine responses to chronic infusion of estradiol-17β. Am J Physiol 1993; 265: E690-E698.
96. Brosnihan KB, Weedle D, Anthony MS, Ferrario CM. Does chronic estrogen act as a converting enzyme inhibitor in postmenopausal cynomolgous monkeys? Am J Hypertens 1995; 8: 107A (Abstr.).
97. Proudler AJ, Hasib Ahmed AI, Crook D, Fogelman I, Rymer JM, Stevenson JC. Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women. Lancet 1995; 346: 89-90.